This early study is testing a new self-adjusting drainage device implanted in the eye to help control pressure in glaucoma patients. The device is designed for people whose eye pressure isn't well controlled by standard eye drop medications. Researchers will follow 10 participant…
Phase: PHASE1 • Sponsor: Rheon Medical SA • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC